Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Multiplex Assays Market from 2024 to 2025?

In the past few years, the market size for multiplex assays has seen significant growth. It is projected to further increase from $3.67 billion in 2024 to $3.92 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this progress during the historic period include heightened health care spending, the expansion of emerging markets, swift technological advancements, and a rapidly aging population.

What Is the Projected Market Size of the Multiplex Assays Market?

The market size of multiplex assays is predicted to experience a significant increase over the next few years, reaching $5.42 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 8.4%. This anticipated growth during the projection period is linked to factors such as increased funding, governmental policies supporting genetic and microbiological research, an aging demographic, a higher rate of chronic illnesses, and a swift increase in various bacterial and viral pandemics. Key trends expected during the forecast period mirror these driving factors, including enhanced funding, further government support for genetic and microbiological studies, an aging populace, a rise in chronic disease prevalence, and a sharp surge in differing bacterial and viral outbreaks.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5775&type=smp

Who are the Major Competitors in the Multiplex Assays Market Outlook?

Major companies operating in the multiplex assays market include Seegene Inc, DiaSorin SpA, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Abcam Plc, PerkinElmer Inc, Hologic Corporation, Meso Scale Diagnostics, Merck KGaA, Roche Diagnostics India Pvt Ltd, bioMérieux India, Becton Dickinson Private Limited, Danaher Corporation, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc. India, Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers Ukraine, TestLine Clinical Diagnostics s.r.o., Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Faizyme Laboratories, Alere Inc., Bangs Laboratories Inc, The Merck Group, Takara Bio Inc, Qiagen, Spherotech Inc, Geneaid Biotech Ltd, Rockland Immunochemicals Inc, GenScript Biotech Corporation

What Is Fueling Growth in the Multiplex Assays Market?

The surge in chronic illnesses is fueling the expansion of the worldwide multiplex assay market. A multiplex assay, widely utilized in clinical studies, serves to scrutinize and gauge disease efficacy and identify antibodies against these diseases. For example, a report by the World Health Organization, a Switzerland-based United Nations health organization, in September 2023 indicated that chronic diseases, also referred to as non-communicable diseases (NCDs), account for 74% of global fatalities, equating to 41 million deaths. Consequently, the increasing prevalence of chronic diseases is pushing the growth of the global multiplex assay market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5775&type=smp

Which Multiplex Assays Market Segments Are Growing the Fastest?

The multiplex assays market covered in this report is segmented –

1) By Type: Protein-Based Multiplex Assays, Nucleic Acid-Based Multiplex Assays, Other Types

2) By Identification Technology: Flow Cytometry, Multiplex Real-Time PCR, Other Identification Technologies

3) By Detection Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Luminescence, Fluorescence, Other Detection Technologies

4) By Application: Research And Development, Clinical Diagnostics

5) By End User: Pharmaceutical And Biotechnology Companies, Hospitals And Research Institutes, Reference Laboratories, Other End-Users

Subsegments:

1) By Protein-Based Multiplex Assays: ELISA (Enzyme-Linked Immunosorbent Assay), Luminex xMAP Technology, Western Blotting, Immunohistochemistry, Mass Spectrometry-Based Assays

2) By Nucleic Acid-Based Multiplex Assays: PCR (Polymerase Chain Reaction), qPCR (Quantitative PCR), NGS (Next-Generation Sequencing), Microarray Analysis, RT-PCR (Reverse Transcription PCR)

3) By Other Types: Cell-Based Multiplex Assays, Bioanalytical Assays, Imaging-Based Assays, Surface Plasmon Resonance (SPR) Assays

Which Industry Trends Are Shaping the Future of the Multiplex Assays Market?

Market players are introducing ground-breaking tests that utilize multiplex assays to solidify their market position. For instance, QuantuMDx Group Limited, a UK-based firm specializing in game-changing point-of-care diagnostics, in May 2022 introduced their latest respiratory panel test, the Q-POC SARS-CoV-2, Flu A/B, and RSV (respiratory syncytial virus) Assay. This Q-POCTM SARS (severe acute respiratory syndrome)-CoV-2, Flu A/B, and RSV Assay is a multiplexed panel that has the ability to identify SARS-CoV-2, Flu A, Flu B, and RSV (respiratory syncytial virus) at the point of demand.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/multiplex-assays-global-market-report

Which Countries Are Leading the Multiplex Assays Market?

North America was the largest region in the multiplex assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5775

This Report Delivers Insight On:

1. How big is the multiplex assays market, and how is it changing globally?

2. Who are the major companies in the multiplex assays market, and how are they performing?

3. What are the key opportunities and risks in the multiplex assays market right now?

4. Which products or customer segments are growing the most in the multiplex assays market?

5. What factors are helping or slowing down the growth of the multiplex assays market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model